NCT06805669Recruiting
This is a Randomized Study of Early Involvement of Palliative Care Along Side Standard Treatment Versus Standard Treatment Alone in Newly Diagnosed Patients With Advanced or Metastatic Soft Tissue Sarcoma (SARQUALITY)
Integrating Early Palliative Care in Advanced SARcoma Patients for Enhanced QUALITY of Life: the SARQUALITY Study
Source: ClinicalTrials.gov · Last updated 3 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this study is to learn whether early referral to palliative care improves quality of life for patients with advanced sarcoma. Participants enrolled in this study will complete quality of life questionnaires before starting their treatment, and every 6 weeks for 24 weeks.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 136 (estimated)
- First submitted
- 23 Jan 2025
- Start date
- Mar 2024
- Primary completion date
- Apr 2027
- Lead sponsor
- Mount Sinai Hospital, Canada
- Diseases
- Sarcoma
- NCT number
- NCT06805669
What you commit to
- Study type: Interventional
- Planned participants: 136
- From Mar 2024 to the primary completion date, Apr 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Clinical evidence of cognitive impairment that would preclude the ability to provide informed consent and complete questionnaires, at investigator´s discretion.
- Active psychiatric disorder or drug abuse.
Other
- Patient in need of urgent home support services or symptom management through a palliative care team.
- Patient is being actively followed by a palliative care physician.
- Insufficient English literacy to complete questionnaires.
Who the study is looking for
- Signed written and voluntary informed consent.
- Have histologically documented advanced sarcoma, either locally advanced not amenable to curative treatment, or metastatic.
- Age ≥ 18 years.
- Have not received any previous systemic treatment with palliative intent for advanced sarcoma.
- Performance status of 0-2 on the Eastern Cooperative Oncology Group (ECOG) performance scale.
- Life expectancy \> 6 months.
- Willing/able to complete questionnaires.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mount Sinai Hospital Coordinator of this site? Confirm its status | Toronto | Canada | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.